These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36535668)

  • 1. Exercise and Airway Clearance Techniques in Cystic Fibrosis.
    Ward N; Stiller K; Holland AE
    Semin Respir Crit Care Med; 2023 Apr; 44(2):209-216. PubMed ID: 36535668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators.
    Wajda KE; Roesch EA; Gifford AH
    Curr Opin Pulm Med; 2023 Nov; 29(6):580-586. PubMed ID: 37611027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can exercise replace airway clearance techniques in cystic fibrosis? A survey of patients and healthcare professionals.
    Rowbotham NJ; Smith SJ; Davies G; Daniels T; Elliott ZC; Gathercole K; Rayner OC; Smyth AR
    J Cyst Fibros; 2020 Jul; 19(4):e19-e24. PubMed ID: 31740105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway clearance after highly effective CFTR modulators: Normalizing life and reducing treatment burden.
    Goetz DM; Frederick CK; Perez G; Borowitz D
    Pediatr Pulmonol; 2023 Aug; 58(8):2375-2380. PubMed ID: 37232336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise intolerance in cystic fibrosis-the role of CFTR modulator therapies.
    Caterini JE; Ratjen F; Barker AR; Williams CA; Rendall K; Schneiderman JE; Wells GD
    J Cyst Fibros; 2022 Mar; 21(2):282-292. PubMed ID: 34955387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators.
    Burke A; Thomson RM; Wainwright CE; Bell SC
    Semin Respir Crit Care Med; 2023 Apr; 44(2):287-296. PubMed ID: 36649736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis liver disease in the post-modulator era.
    Narkewicz MR
    Curr Opin Pulm Med; 2023 Nov; 29(6):621-625. PubMed ID: 37678151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.
    McIlwaine M; Button B; Dwan K
    Cochrane Database Syst Rev; 2015 Jun; (6):CD003147. PubMed ID: 26083308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telehealth and CFTR modulators: Accelerating innovative models of cystic fibrosis care.
    Prickett MH; Flume PA; Sabadosa KA; Tran QT; Marshall BC
    J Cyst Fibros; 2023 Jan; 22(1):9-16. PubMed ID: 35879227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey: Understanding the health and perspectives of people with CF not benefiting from CFTR modulators.
    Kramer-Golinkoff E; Camacho A; Kramer L; Taylor-Cousar JL
    Pediatr Pulmonol; 2022 May; 57(5):1253-1261. PubMed ID: 35170259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical impact of the Covid-19 pandemic first wave on patients with cystic fibrosis in New York.
    Simonson JL; Esposito C; Frantzen T; Henthorne K; Espinal A; Romano S; Ramdeo R; Trentacoste J; Tsang D; LaVecchia G; Abdullah R; Berdella M; Bonitz L; Condos R; Constantinescu A; DeCelie-Germana JK; DiMango E; Draine M; Gimeli T; Giusti R; Guzman J; Hammouda S; Keating C; Kier C; Lennox AT; Liriano C; Messer Z; Plachta A; Sadeghi H; Schwind E; Stables-Carney T; Walker P; Wang J
    J Cyst Fibros; 2022 May; 21(3):e176-e183. PubMed ID: 35256307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway clearance and exercise for people with cystic fibrosis: Balancing longevity with life.
    Rowbotham NJ; Daniels TE
    Pediatr Pulmonol; 2022 Feb; 57 Suppl 1():S50-S59. PubMed ID: 34672434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of cystic fibrosis care: a global perspective.
    Bell SC; Mall MA; Gutierrez H; Macek M; Madge S; Davies JC; Burgel PR; Tullis E; Castaños C; Castellani C; Byrnes CA; Cathcart F; Chotirmall SH; Cosgriff R; Eichler I; Fajac I; Goss CH; Drevinek P; Farrell PM; Gravelle AM; Havermans T; Mayer-Hamblett N; Kashirskaya N; Kerem E; Mathew JL; McKone EF; Naehrlich L; Nasr SZ; Oates GR; O'Neill C; Pypops U; Raraigh KS; Rowe SM; Southern KW; Sivam S; Stephenson AL; Zampoli M; Ratjen F
    Lancet Respir Med; 2020 Jan; 8(1):65-124. PubMed ID: 31570318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to inhaled antibiotics in people with cystic fibrosis: insights from a virtual patient advisory board.
    Gambazza S; Storms V; Purohit V
    Expert Rev Respir Med; 2023; 17(10):961-963. PubMed ID: 37817635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility and Pregnancy in Cystic Fibrosis.
    Shteinberg M; Taylor-Cousar JL; Durieu I; Cohen-Cymberknoh M
    Chest; 2021 Dec; 160(6):2051-2060. PubMed ID: 34284004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidance and standard operating procedures for functional exercise testing in cystic fibrosis.
    Saynor ZL; Gruet M; McNarry MA; Button B; Morrison L; Wagner M; Sawyer A; Hebestreit H; Radtke T; Urquhart DS;
    Eur Respir Rev; 2023 Sep; 32(169):. PubMed ID: 37558263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa infection, but not mono or dual-combination CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosis.
    Westhölter D; Beckert H; Straßburg S; Welsner M; Sutharsan S; Taube C; Reuter S
    J Cyst Fibros; 2021 Nov; 20(6):1072-1079. PubMed ID: 34030985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced Cystic Fibrosis Lung Disease and Lung Transplantation in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulators.
    O'Carroll M
    Semin Respir Crit Care Med; 2023 Apr; 44(2):260-268. PubMed ID: 36893762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rethinking physical exercise training in the modern era of cystic fibrosis: A step towards optimising short-term efficacy and long-term engagement.
    Gruet M; Saynor ZL; Urquhart DS; Radtke T
    J Cyst Fibros; 2022 Mar; 21(2):e83-e98. PubMed ID: 34493444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.
    Naehrlich L; Orenti A; Dunlevy F; Kasmi I; Harutyunyan S; Pfleger A; Keegan S; Daneau G; Petrova G; Tješić-Drinković D; Yiallouros P; Bilkova A; Olesen HV; Burgel PR; Parulava T; Diamantea F; Párniczky A; McKone EF; Mei-Zahav M; Salvatore M; Colombo C; Aleksejeva E; Malakauskas K; Schlesser M; Fustik S; Turcu O; Zomer-van Ommen D; Wathne AS; Woźniacki Ł; Pereira L; Pop L; Kashirskaya N; Rodić M; Kayserova H; Krivecs U; Mondejar-Lopez P; de Monestrol I; Dogru D; Makukh H; Cosgriff R; van Koningsbruggen-Rietschel S; Jung A;
    J Cyst Fibros; 2021 Jul; 20(4):566-577. PubMed ID: 34016559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.